ORION CORPORATION MANAGERS’ TRANSACTIONS 23 JULY 2021 at 15.30 EEST Orion Oyj: Correction of the content of the Managers’s transaction notification CORRECTION: Orion Corporation: Managers’ transactions – Liisa Hurme Orion Corporation is correcting its stock exchange release from 23 July 2021 at 15.00 EEST. The present release is based on the amended Managers’ transactions notification received by the company. In the initial notification, the box “Legal person” was erroneously ticked. Additionally, the amended notification specifies the dates of the transactions. The following are the contents of the amended Managers’ transactions notification: Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj – Managers’ Transactions____________________________________________ Person subject to the notification requirementName: Aino Anna Liisa HurmePosition: Other senior managerIssuer: Orion OyjLEI: 74370029VAHCXDR7B745 Notification type: AMENDMENTReference number: 74370029VAHCXDR7B745_20210723122117_6Amendment comment:Amendment to the initial notification where “Legal person” was erroneously ticked. Also added another page for transaction carried out on 23 July 2021.____________________________________________ Transaction date: 2021-07-22Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009014377Nature of the transaction: DISPOSAL Transaction details(1): Volume: 1,000 Unit price: 35.01 EUR(2): Volume: 1,000 Unit price: 35.008 EUR(3): Volume: 5,000 Unit price: 35.1 EUR Aggregated transactions(3): Volume: 7,000 Volume weighted average price: 35.074 EUR____________________________________________ Transaction date: 2021-07-23Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009014377Nature of the transaction: DISPOSAL Transaction details(1): Volume: 5,700 Unit price: 35.3 EUR Aggregated transactions(1): Volume: 5,700 Volume weighted average price: 35.3 EUR Orion Corporation Timo LappalainenPresident and CEO Olli HuotariSVP, Corporate Functions Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200 Espoo, Finlandhttp://www.orion.fi/enhttp://www.twitter.com/OrionCorpIR Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion’s net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.